Skip to content

Chronic Sucrose Intake, Markers of Health and Biomarker Identification

Investigation of Sucrose-induced Metabolic Adaptation and Biomarkers of Chronic Sucrose Intake in Humans Using a Multi-omic Approach

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04486105
Enrollment
60
Registered
2020-07-24
Start date
2020-01-01
Completion date
2022-02-01
Last updated
2020-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dietary Exposure, Metabolic Disturbance

Brief summary

With free sugar intake proving to be of a concern within the general public, discovery and validation of a new biomarker will allow for more consistent measurement of sucrose intake. Furthermore, using a multi-omic approach the investigators will identify metabolic perturbations to the metabolome and proteome.

Detailed description

Excessive free sugar intake is of concern within the general public, as intakes have been associated with weight gain and cardiovascular disease. Average intakes are over double that of the 5% of total energy intake that is recommended by the Science Advisory Committee on Nutrition, but intakes are calculated from observational measures that lack sensitivity and discovery and validation of a new biomarker from biological fluids may allow for more specific measurement and a better understanding of intake:disease relationships. Furthermore, understanding the biochemistry of sucrose intake will allow the identification of damage occurrence and alternative metabolic pathways, as well as novel protein damage that occur with chronic sucrose exposure. This study aims to identify a biomarker of chronic sucrose consumption using metabolite profiling technology. The study will be composed of a randomised controlled intervention trial, in which participants will be required to consume an amount of sucrose (0-120g/d) every day for 7 days and provide biofluid samples (urine and blood) before the initiation, during and following the intervention; that will undergo metabolic analysis. Furthermore, participants will have their anthropometrics and dietary intake monitored throughout the study. The biomarker will also be validated against the dietary information and correlated with indices of health and sucrose-induced damage. The investigators will also monitor the feasibility and acceptability of chronic sucrose intake during the intervention.

Interventions

DIETARY_SUPPLEMENTsucrose

pure sucrose in water in addition to habitual diet

Sponsors

Northumbria University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Intervention model description

RCT

Eligibility

Sex/Gender
ALL
Age
19 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 19-64, healthy diagnosis

Exclusion criteria

* gastrointestinal issues, doesn't consume sugar

Design outcomes

Primary

MeasureTime frameDescription
Blood pressurechange in blood pressure following one week interventionMeasurement of systolic and diastolic blood pressure
Metabolomechange in the urinary metabolome following one week interventionMetabolite profiling of urine samples, obtaining a profile of approximately 5000 metabolite intensities in urine
Body compositionchange in body mass index following one week interventionmeasurement of body mass index

Secondary

MeasureTime frameDescription
food diary analysischange in dietary intake following the week interventionmeasurement of energy, macro and micronutrient intakes from 3-day food diaries

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026